Page 36 - JCBP-2-1

Journal of Clinical and
Basic Psychosomatics The endocannabinoid system

Acknowledgments 5. Sharma DS, Paddibhatla I, Raghuwanshi S, et al., 2021,
Endocannabinoid system: Role in blood cell development,
None. neuroimmune interactions and associated disorders.
J Neuroimmunol, 353: 577501.
Funding
https://doi.org/10.1016/j.jneuroim.2021.577501
None.
6. Steardo L Jr., Carbone EA, Menculini G, et al., 2021,
Conflict of interest Endocannabinoid system as therapeutic target of PTSD:
A systematic review. Life, 11: 214.
The authors declare no conflicts of interest associated with https://doi.org/10.3390/life11030214
the completion and submission of this review. They have
no financial or personal relationships with individuals or 7. Song C, Kang X, Yang F, et al., 2021, Endocannabinoid system
organizations that could potentially bias the content or in the neurodevelopment of GABAergic interneurons:
influence the interpretation of the information presented Implications for neurological and psychiatric disorders. Rev
Neurosci, 32: 803–831.
in this review.
https://doi.org/10.1515/revneuro-2020-0134
Author contributions 8. Amatriain-Fernández S, Budde H, Gronwald T, et al., 2021,
Conceptualization: Alberto K. De la Herrán-Arita The endocannabinoid system as modulator of exercise
Writing – original draft: All authors benefits in mental health. Curr Neuropharmacol, 19:
Writing – review & editing: Laura Torres-Mondragón, 1304–1322.
Alberto K. De la Herrán-Arita https://doi.org/10.2174/1570159x19666201218112748

Ethics approval and consent to participate 9. Thurner C, Horing B, Zipfel S, et al., 2022, Autonomic
changes as reaction to experimental social stress in
Not applicable. an inpatient psychosomatic cohort. Front Psychiatry,
13: 817778.
Consent for publication https://doi.org/10.3389/fpsyt.2022.817778

Not applicable. 10. Rees L, 1959, The role of stress in the aetiology of
psychosomatic disorders. Proc R Soc Med, 52: 274–278.
Availability of data
11. Gieler U, Gieler T, Peters EMJ, et al., 2020, Skin and
Not applicable. psychosomatics-psychodermatology today. J Dtsch Dermatol
Ges= J Ger Soc Dermatol, 18: 1280–1298.
References
https://doi.org/10.1111/ddg.14328
1. Masuda A, Yamanaka T, Hirakawa T, et al., 2007, Intra-and
extra-familial adverse childhood experiences and a history 12. American Psychiatric Association, 2022, DSM-5 TM
of childhood psychosomatic disorders among Japanese Guidebook the Essential Companion to the Diagnostic and
th
university students. BioPsychoSoc Med, 1: 9. Statistical Manual of Mental Disorders. 5 ed. Washington,
DC: American Psychiatric Publishing.
https://doi.org/10.1186/1751-0759-1-9
13. Zefferino R, Di Gioia S, Conese, M, 2020, Molecular links
2. Figueiredo-Ferraz H, Gil-Monte PR, Grau-Alberola E, et al., between endocrine, nervous and immune system during
2021, The mediator role of feelings of guilt in the process chronic stress. Brain Behav, 11: e01960.
of burnout and psychosomatic disorders: A cross-cultural
study. Front Psychol, 12: 751211. https://doi.org/10.1002/brb3.1960
14. Mikulska J, Juszczyk G, Gawrońska-Grzywacz M, et al.,
https://doi.org/10.3389/fpsyg.2021.751211
2021, HPA axis in the pathomechanism of depression and
3. Bransfield RC, Friedman KJ, 2019, Differentiating schizophrenia: New therapeutic strategies based on its
psychosomatic, somatopsychic, multisystem illnesses, and participation. Brain Sci, 11: 1298.
medical uncertainty. Healthcare (Basel), 7: 114.
https://doi.org/10.3390/brainsci11101298
https://doi.org/10.3390/healthcare7040114
15. Sheng JA, Bales NJ, Myers SA, et al., 2021, The hypothalamic-
4. Burton C, Fink P, Henningsen P, et al., 2020, Functional pituitary-adrenal axis: Development, programming actions
somatic disorders: Discussion paper for a new common of hormones, and maternal-fetal interactions. Front Behav
classification for research and clinical use. BMC Med, 18: 34. Neurosci, 14: 601939.
https://doi.org/10.1186/s12916-020-1505-4 https://doi.org/10.3389/fnbeh.2020.601939

Volume 2 Issue 1 (2024) 12 https://doi.org/10.36922/jcbp.2288